A population approach to characterise amisulpride pharmacokinetics in older people and Alzheimer’s disease

INTRODUCTION: Current prescribing guidelines for the antipsychotic amisulpride are based largely on pharmacokinetic (PK) studies in young adults, and there is a relative absence of data on older patients, who are at greatest risk of developing adverse events. METHODS: This study aimed to develop a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Reeves, Suzanne, Bertrand, Julie, D’Antonio, Fabrizia, McLachlan, Emma, Nair, Akshay, Brownings, Stuart, Greaves, Suki, Smith, Alan, Taylor, David, Howard, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989015/
https://www.ncbi.nlm.nih.gov/pubmed/27481049
http://dx.doi.org/10.1007/s00213-016-4379-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989015/
https://www.ncbi.nlm.nih.gov/pubmed/27481049
http://dx.doi.org/10.1007/s00213-016-4379-6

Ejemplares similares